TSC-22 D4 Antibodies

Santa Cruz Biotechnology delivers a wide array of Tsc-22 D4 monoclonal antibodies for research applications. Tsc-22 D4 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Tsc-22, also known as TGF-beta-stimulated clone 22, plays a crucial role in regulating cellular responses to stress and inflammation. Tsc-22 is involved in various biological processes, including apoptosis, cell differentiation, and immune response modulation. Understanding Tsc-22 function is essential for elucidating its role in disease mechanisms and potential therapeutic targets. Research has shown that Tsc-22 expression levels are altered in several pathological conditions, making it an important focus for scientific investigation. Tsc-22 has emerged as a significant factor in cellular signaling pathways and developmental processes. Multiple studies have demonstrated Tsc-22's involvement in tissue homeostasis and disease progression. Santa Cruz Biotechnology monoclonal antibodies for Tsc-22 D4 enable researchers to advance scientific understanding of cellular mechanisms and disease pathways.